Sorrento Therapeutics Opened Up 11.7% After CEO Slams Short Sellers
Most companies don't comment on outside reports. Sorrento Therapeutics' (NASDAQ: SRNE) President and CEO Henry Ji even says that's generally the biotech's policy.
Then he went off on short sellers in an interview posted in a tweet by RagingBull yesterday afternoon.
"I am giving them a fair warning shot. Just cover yourself, don't ruin your family," Ji said of short sellers who he says are trying to manipulate Sorrento's stock.
Source Fool.com
